The Potential of Repurposing BCMA-Targeted Biologics for Treating Autoimmune Diseases

Time: 4:30 pm
day: Day One


  • Understanding the multitude of unmet medical needs which could be addressed with a BCMA-targeted biologic
  • Exploring how the pharmacology of antibodies can be similar in healthy volunteers, autoimmune and oncology patients
  • Learning how antibodies which are effective in treating hematopoietic malignancies have also been re-purposed for the effective treatment of autoimmune diseases